Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Connect with investors, share insights, and grow together
Stay up to date on latest investing trends and other announcements
Explore our range of financial tools to streamline your investment planning
A structured, comprehensive way to understand global investing
Read about our journey and get to know the leadership team at Vested
The fund will invest at least 80% of its net assets (plus borrowings for investment purposes) in instruments in its underlying index or in instruments that have economic characteristics similar to those in the underlying index. The underlying index is a free float adjusted market capitalization weighted index, subject to the 10/40 Constraint, which is designed to measure the equity market performance of Chinese companies in the healthcare sector. The fund is non-diversified. more
| Time Frame | KURE | S&P500 |
|---|---|---|
| 1-Week Return | 7.29% | 2.88% |
| 1-Month Return | 11.65% | 2.81% |
| 3-Month Return | 6.74% | 5.03% |
| 6-Month Return | 2.15% | 10.68% |
| 1-Year Return | -3.79% | 21.52% |
| 3-Year Return | 5.4% | 70.6% |
| 5-Year Return | -53.51% | 73.79% |
| 10-Year Return | -25% | 253.08% |
| Time Frame | KURE | S&P500 |
|---|---|---|
| 1-Week Return | 3,821.45% | 339.51% |
| 1-Month Return | 282.19% | 40.10% |
| 3-Month Return | 30.28% | 22.02% |
| 6-Month Return | 4.41% | 22.85% |
| 1-Year Return | -3.79% | 21.52% |
| 3-Year Return | 1.77% | 19.49% |
| 5-Year Return | -14.20% | 11.69% |
| 10-Year Return | -2.84% | 13.45% |
| Stock name | Ticker | Weight |
|---|---|---|
BEONE MEDICINES LTD-H | 6160.HK | 9.27% |
INNOVENT BIOLOGICS INC | 1801.HK | 8.79% |
WUXI BIOLOGICS CAYMAN INC | 2269.HK | 8.08% |
WUXI APPTEC CO LTD-A | 603259.SS | 5.95% |
SHENZHEN MINDRAY BIO-MEDIC-A | 300760.SZ | 4.23% |
JIANGSU HENGRUI PHARMACEUT-A | 600276.SS | 4.12% |
AKESO INC | 9926.HK | 3.81% |
CSPC PHARMACEUTICAL GROUP LT | 1093.HK | 3.69% |
WUXI APPTEC CO LTD-H | 2359.HK | 3.51% |
SINO BIOPHARMACEUTICAL | 1177.HK | 3.42% |
HANSOH PHARMACEUTICAL GROUP | 3692.HK | 2.77% |
3SBIO INC | 1530.HK | 2.3% |
SHANGHAI UNITED IMAGING HE-A | 688271.SS | 2.25% |
YUNNAN BAIYAO GROUP CO LTD-A | 000538.SZ | 2.22% |
ZHANGZHOU PIENTZEHUANG PHA-A | 600436.SS | 2.01% |
AIER EYE HOSPITAL GROUP CO-A | 300015.SZ | 2% |
SICHUAN KELUN-BIOTECH BIOP-H | 6990.HK | 1.99% |
SICHUAN BIOKIN PHARMACEUTI-A | SICHUAN.BIOKIN.PHARMACEUTI.A | 1.84% |
GENSCRIPT BIOTECH CORP | 1548.HK | 1.68% |
SICHUAN KELUN PHARMACEUTIC-A | 002422.SZ | 1.67% |
SINOPHARM GROUP CO-H | 1099.HK | 1.61% |
HAISCO PHARMACEUTICAL GROU-A | 002653.SZ | 1.43% |
PHARMARON BEIJING CO LTD-A | 300759.SZ | 1.41% |
SHANGHAI ALLIST PHARMACEUT-A | 688578.SS | 1.22% |
HUADONG MEDICINE CO LTD-A | 000963.SZ | 1.21% |
WUXI XDC CAYMAN INC | 2268.HK | 1.18% |
SHANGHAI FOSUN PHARMACEUTI-A | 600196.SS | 1.18% |
SHANGHAI PHARMACEUTICALS-A | 601607.SS | 1.12% |
REMEGEN CO LTD-H | 9995.HK | 1.06% |
REMEGEN CO LTD-A | 688331.SS | 1.03% |
CHINA RESOURCES SANJIU MED-A | 000999.SZ | 1.02% |
SHENZHEN SALUBRIS PHARM-A | 002294.SZ | 0.93% |
SHENZHEN NEW INDUSTRIES BI-A | 300832.SZ | 0.91% |
XTALPI HOLDINGS LTD | 2228.HK | 0.89% |
CSPC INNOVATION PHARMACEUT-A | 300765.SZ | 0.87% |
BEIJING TONG REN TANG CO-A | 600085.SS | 0.83% |
LEGEND BIOTECH CORP-ADR | LEGN | 0.82% |
SHANGHAI RAAS BLOOD PRODUC-A | 002252.SZ | 0.8% |
CHANGCHUN HIGH-TECH INDUST-A | 000661.SZ | 0.75% |
CHONGQING ZHIFEI BIOLOGICA-A | 300122.SZ | 0.75% |
IMEIK TECHNOLOGY DEVELOPME-A | 300896.SZ | 0.75% |
APT MEDICAL INC-A | 688617.SS | 0.73% |
BEIJING WANTAI BIOLOGICAL-A | 603392.SS | 0.65% |
HEBEI CHANGSHAN BIOCHEMICA-A | 300255.SZ | 0.57% |
HANGZHOU TIGERMED CONSULTI-A | 300347.SZ | 0.42% |
Cash | Cash | 0.26% |
HONG KONG DOLLAR | HONG.KONG.DOLLAR | 0% |
KANGMEI PHARMA - RIGHTS O | KANGMEI.PHARMA...RIGHTS.O | 0% |
| Sector | Weight |
|---|---|
|
Health care | 99.19% |
|
Consumer staples | 0.81% |
KraneShares MSCI All China Health Care Index ETF (KURE) share price today is $18.5399.
Yes, Indians can buy shares of KraneShares MSCI All China Health Care Index ETF (KURE) on Vested. To buy KURE from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of KraneShares MSCI All China Health Care Index ETF (KURE) on Vested. You can start investing in KraneShares MSCI All China Health Care Index ETF (KURE) with a minimum investment of $1.
The 52-week high price of KraneShares MSCI All China Health Care Index ETF (KURE) is $21.04. The 52-week low price of KraneShares MSCI All China Health Care Index ETF (KURE) is $14.38.
The stock symbol (or ticker) of KraneShares MSCI All China Health Care Index ETF is KURE.
Yes, you can setup SIP in KraneShares MSCI All China Health Care Index ETF shares. Follow the below steps to create the SIP:
Here is the historical performance of KURE on the Vested app.
The expense ratio of KraneShares MSCI All China Health Care Index ETF (KURE) is 0.65%.
Link copied